- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.51 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x GLV: GLYOXYLIC ACID(Non-covalent)
- 6 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 4 residues within 4Å:- Chain A: R.84, E.158, D.192
- Ligands: GLV.1
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.158, A:D.192, H2O.1, H2O.1
MG.14: 4 residues within 4Å:- Chain B: R.84, E.158, D.192
- Ligands: GLV.12
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.158, B:D.192, H2O.6, H2O.6
MG.25: 4 residues within 4Å:- Chain C: R.84, E.158, D.192
- Ligands: GLV.23
4 PLIP interactions:2 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.158, C:D.192, H2O.11, H2O.11
MG.36: 4 residues within 4Å:- Chain D: R.84, E.158, D.192
- Ligands: GLV.34
4 PLIP interactions:2 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:E.158, D:D.192, H2O.16, H2O.16
MG.47: 4 residues within 4Å:- Chain E: R.84, E.158, D.192
- Ligands: GLV.45
4 PLIP interactions:2 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:E.158, E:D.192, H2O.21, H2O.21
MG.58: 4 residues within 4Å:- Chain F: R.84, E.158, D.192
- Ligands: GLV.56
4 PLIP interactions:2 interactions with chain F, 2 Ligand-Water interactions- Metal complexes: F:E.158, F:D.192, H2O.26, H2O.27
- 30 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 5 residues within 4Å:- Chain A: V.226, A.227, G.252
- Chain B: R.198
- Ligands: K.9
Ligand excluded by PLIPCL.5: 5 residues within 4Å:- Chain A: R.89, D.90, S.91, P.92, R.95
Ligand excluded by PLIPCL.6: 5 residues within 4Å:- Chain A: R.218
- Chain B: R.218
- Chain C: R.218
- Ligands: CL.17, CL.28
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain A: P.207, A.208
Ligand excluded by PLIPCL.8: 4 residues within 4Å:- Chain A: G.126, I.127, A.165
- Chain C: R.170
Ligand excluded by PLIPCL.15: 5 residues within 4Å:- Chain B: V.226, A.227, G.252
- Chain C: R.198
- Ligands: K.20
Ligand excluded by PLIPCL.16: 5 residues within 4Å:- Chain B: R.89, D.90, S.91, P.92, R.95
Ligand excluded by PLIPCL.17: 5 residues within 4Å:- Chain A: R.218
- Chain B: R.218
- Chain C: R.218
- Ligands: CL.6, CL.28
Ligand excluded by PLIPCL.18: 2 residues within 4Å:- Chain B: P.207, A.208
Ligand excluded by PLIPCL.19: 4 residues within 4Å:- Chain A: R.170
- Chain B: G.126, I.127, A.165
Ligand excluded by PLIPCL.26: 5 residues within 4Å:- Chain A: R.198
- Chain C: V.226, A.227, G.252
- Ligands: K.31
Ligand excluded by PLIPCL.27: 5 residues within 4Å:- Chain C: R.89, D.90, S.91, P.92, R.95
Ligand excluded by PLIPCL.28: 5 residues within 4Å:- Chain A: R.218
- Chain B: R.218
- Chain C: R.218
- Ligands: CL.6, CL.17
Ligand excluded by PLIPCL.29: 2 residues within 4Å:- Chain C: P.207, A.208
Ligand excluded by PLIPCL.30: 4 residues within 4Å:- Chain B: R.170
- Chain C: G.126, I.127, A.165
Ligand excluded by PLIPCL.37: 5 residues within 4Å:- Chain D: V.226, A.227, G.252
- Chain E: R.198
- Ligands: K.42
Ligand excluded by PLIPCL.38: 5 residues within 4Å:- Chain D: R.89, D.90, S.91, P.92, R.95
Ligand excluded by PLIPCL.39: 5 residues within 4Å:- Chain D: R.218
- Chain E: R.218
- Chain F: R.218
- Ligands: CL.50, CL.61
Ligand excluded by PLIPCL.40: 2 residues within 4Å:- Chain D: P.207, A.208
Ligand excluded by PLIPCL.41: 4 residues within 4Å:- Chain D: G.126, I.127, A.165
- Chain F: R.170
Ligand excluded by PLIPCL.48: 5 residues within 4Å:- Chain E: V.226, A.227, G.252
- Chain F: R.198
- Ligands: K.53
Ligand excluded by PLIPCL.49: 5 residues within 4Å:- Chain E: R.89, D.90, S.91, P.92, R.95
Ligand excluded by PLIPCL.50: 5 residues within 4Å:- Chain D: R.218
- Chain E: R.218
- Chain F: R.218
- Ligands: CL.39, CL.61
Ligand excluded by PLIPCL.51: 2 residues within 4Å:- Chain E: P.207, A.208
Ligand excluded by PLIPCL.52: 4 residues within 4Å:- Chain D: R.170
- Chain E: G.126, I.127, A.165
Ligand excluded by PLIPCL.59: 5 residues within 4Å:- Chain D: R.198
- Chain F: V.226, A.227, G.252
- Ligands: K.64
Ligand excluded by PLIPCL.60: 5 residues within 4Å:- Chain F: R.89, D.90, S.91, P.92, R.95
Ligand excluded by PLIPCL.61: 5 residues within 4Å:- Chain D: R.218
- Chain E: R.218
- Chain F: R.218
- Ligands: CL.39, CL.50
Ligand excluded by PLIPCL.62: 2 residues within 4Å:- Chain F: P.207, A.208
Ligand excluded by PLIPCL.63: 4 residues within 4Å:- Chain E: R.170
- Chain F: G.126, I.127, A.165
Ligand excluded by PLIP- 18 x K: POTASSIUM ION(Non-covalent)
K.9: 5 residues within 4Å:- Chain A: S.217, S.221, G.252
- Chain B: M.197
- Ligands: CL.4
Ligand excluded by PLIPK.10: 5 residues within 4Å:- Chain A: M.173, G.174, K.175, N.178, E.181
Ligand excluded by PLIPK.11: 3 residues within 4Å:- Chain A: P.176, N.178, N.179
Ligand excluded by PLIPK.20: 5 residues within 4Å:- Chain B: S.217, S.221, G.252
- Chain C: M.197
- Ligands: CL.15
Ligand excluded by PLIPK.21: 5 residues within 4Å:- Chain B: M.173, G.174, K.175, N.178, E.181
Ligand excluded by PLIPK.22: 3 residues within 4Å:- Chain B: P.176, N.178, N.179
Ligand excluded by PLIPK.31: 5 residues within 4Å:- Chain A: M.197
- Chain C: S.217, S.221, G.252
- Ligands: CL.26
Ligand excluded by PLIPK.32: 5 residues within 4Å:- Chain C: M.173, G.174, K.175, N.178, E.181
Ligand excluded by PLIPK.33: 3 residues within 4Å:- Chain C: P.176, N.178, N.179
Ligand excluded by PLIPK.42: 5 residues within 4Å:- Chain D: S.217, S.221, G.252
- Chain E: M.197
- Ligands: CL.37
Ligand excluded by PLIPK.43: 5 residues within 4Å:- Chain D: M.173, G.174, K.175, N.178, E.181
Ligand excluded by PLIPK.44: 3 residues within 4Å:- Chain D: P.176, N.178, N.179
Ligand excluded by PLIPK.53: 5 residues within 4Å:- Chain E: S.217, S.221, G.252
- Chain F: M.197
- Ligands: CL.48
Ligand excluded by PLIPK.54: 5 residues within 4Å:- Chain E: M.173, G.174, K.175, N.178, E.181
Ligand excluded by PLIPK.55: 3 residues within 4Å:- Chain E: P.176, N.178, N.179
Ligand excluded by PLIPK.64: 5 residues within 4Å:- Chain D: M.197
- Chain F: S.217, S.221, G.252
- Ligands: CL.59
Ligand excluded by PLIPK.65: 5 residues within 4Å:- Chain F: M.173, G.174, K.175, N.178, E.181
Ligand excluded by PLIPK.66: 3 residues within 4Å:- Chain F: P.176, N.178, N.179
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bracken, C.D. et al., Crystal structures of a halophilic archaeal malate synthase from Haloferax volcanii and comparisons with isoforms A and G. Bmc Struct.Biol. (2011)
- Release Date
- 2011-06-01
- Peptides
- Malate synthase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.51 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x GLV: GLYOXYLIC ACID(Non-covalent)
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 30 x CL: CHLORIDE ION(Non-functional Binders)
- 18 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bracken, C.D. et al., Crystal structures of a halophilic archaeal malate synthase from Haloferax volcanii and comparisons with isoforms A and G. Bmc Struct.Biol. (2011)
- Release Date
- 2011-06-01
- Peptides
- Malate synthase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A